Your browser doesn't support javascript.
loading
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
Zhang, Tingting; Liu, Hengqi; Gao, Fenghua; Gong, Wenchen; Cui, Yaoli; He, Jin; Li, Lanfang; Qiu, Lihua; Qian, Zhengzi; Zhou, Shiyong; Meng, Bin; Ren, Xiubao; Zhang, Huilai; Wang, Xianhuo.
Affiliation
  • Zhang T; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Liu H; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
  • Gao F; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Gong W; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
  • Cui Y; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • He J; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
  • Li L; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Qiu L; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Qian Z; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
  • Zhou S; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Meng B; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
  • Ren X; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Zhang H; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China.
  • Wang X; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
Front Immunol ; 13: 922471, 2022.
Article in En | MEDLINE | ID: mdl-35734168
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Tumor Microenvironment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Follicular / Tumor Microenvironment Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland